BUY RHI MAGNESITA INDIA LIMITED — Manas Jaiswal
byManas JaiswalHorizon: NA (inferred Swing (≤2wk))10 Jul 2026via CNBC Awaaz.
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Nothing found in this tip’s window yet.
RHI Magnesita India announced a leadership transition. Details are in a press release dated June 30, 2026.
NSE · Press Release·30 Jun · 1w ago
RHI Magnesita India announces leadership transition. Pankaj Malhan appointed as MD & CEO, effective July 1, 2026. Parmod Sagar will continue as Chairman.
BSE · Company Update·30 Jun · 1w ago
The company has announced changes in its leadership. Parmod Sagar resigns as MD & CEO and becomes Chairman. Pankaj Malhan is appointed as the new MD & CEO. Azim Syed resigns as Whole-time Director but
BSE · Company Update·30 Jun · 1w ago
Parmod Sagar resigns as MD & CEO, will continue as Chairman. Pankaj Malhan appointed as new MD & CEO. Azim Syed resigns as Whole-time Director but continues as CFO.
BSE · Company Update·30 Jun · 1w ago
Parmod Sagar resigns as MD & CEO, will continue as Chairman. Pankaj Malhan appointed as new MD & CEO. Azim Syed resigns as Whole-time Director but continues as CFO.
BSE · Company Update·30 Jun · 1w ago
Parmod Sagar resigns as MD & CEO, effective June 30, 2026, and will continue as Chairman. Pankaj Malhan appointed as new MD & CEO, effective July 1, 2026. Azim Syed resigns as Whole-time Director but
BSE · Company Update·30 Jun · 1w ago
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on RHI MAGNESITA INDIA
- BUY — Nuvama Wealth13 Aug 2026 · ~1 year · target ₹557 · Active
- BUY — Ansh Jogendra Bhilwar12 Aug 2026 · Same day · target ₹432 · SL hit
- BUY — Axis Securities16 Jun 2025 · ~1 year · target ₹550 · Expired
- BUY — Monarch Networth Capital Limited15 Aug 2024 · ~1 year · target ₹700 · Expired
More from Manas Jaiswal
- BUY Ajanta Pharma23 Oct 2026 · Same day · target ₹3,425 · SL hit
- BUY Torrent Pharmaceuticals23 Oct 2026 · Same day · target ₹4,725 · SL hit
- BUY SAGILITY23 Oct 2026 · ~2 weeks · target ₹50 · SL hit
- BUY Zydus Lifesciences22 Oct 2026 · ~3 months · target ₹1,160 · SL hit
- BUY IPCA Laboratories22 Oct 2026 · ~2 weeks · target ₹2,000 · Active

